T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.73 CNY -2.24%
Market Cap: 17B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note

Net Margin
Tonghua Dongbao Pharmaceutical Co Ltd

18.5%
Current
42%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
18.5%
=
Net Income
452.5m
/
Revenue
2.4B

Net Margin Across Competitors

Country CN
Market Cap 17.3B CNY
Net Margin
18%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 746.8B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 365.6B USD
Net Margin
17%
Country US
Market Cap 249.1B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Tonghua Dongbao Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
18.5%
=
Net Income
452.5m
/
Revenue
2.4B
What is the Net Margin of Tonghua Dongbao Pharmaceutical Co Ltd?

Based on Tonghua Dongbao Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 18.5%.